-
Study: 80% of dietary supplement consumers make purchase decision at shelf
SANTA CRUZ, Calif. — Rainbow Light recently released the results of a study conducted by Wiest & Co. that demonstrates that product labels are more important in influencing vitamin and supplement consumer purchases than previously thought.
-
Reckitt Benckiser talks about Mucinex, Airborne line extensions
SLOUGH, England — Reckitt Benckiser has line extended its Mucinex franchise into the year-round allergy sector with Mucinex Allergy, Heather Allen, Reckitt Benckiser EVP category development, told analysts Wednesday.
"Super fantastic launch in the U.S.," she said. "Allergy is a $2.5 billion market in the U.S. More than 75% of Mucinex users also take an allergy treatment, and now, we're able to offer them Mucinex Allergy, maximum strength, non-drowsy antihistamine, acts fast and lasts for 24 hours."